Correlation Between Veracyte and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Silo Pharma, you can compare the effects of market volatilities on Veracyte and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Silo Pharma.

Diversification Opportunities for Veracyte and Silo Pharma

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Veracyte and Silo is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Veracyte i.e., Veracyte and Silo Pharma go up and down completely randomly.

Pair Corralation between Veracyte and Silo Pharma

Given the investment horizon of 90 days Veracyte is expected to generate 0.49 times more return on investment than Silo Pharma. However, Veracyte is 2.06 times less risky than Silo Pharma. It trades about 0.38 of its potential returns per unit of risk. Silo Pharma is currently generating about -0.26 per unit of risk. If you would invest  3,594  in Veracyte on September 16, 2024 and sell it today you would earn a total of  728.00  from holding Veracyte or generate 20.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Silo Pharma

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Veracyte and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Silo Pharma

The main advantage of trading using opposite Veracyte and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind Veracyte and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins